The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study

Marjolein W M van Ruijven1, John C M J de Groot, Sjaak F L Klis

  • 1Hearing Research Laboratories, Department of Otorhinolaryngology, University Medical Center Utrecht, P.O. Box 85.500, 3508 GA Utrecht, The Netherlands. m.vanruijven@kmb.azu.nl

Hearing Research
|June 15, 2005
PubMed

Insights

Cisplatin damages the cochlea, affecting the organ of Corti and spiral ganglion. This study found these ototoxic effects develop in parallel, not influencing each other.

Area of Science:

  • Ototoxicity research
  • Auditory neuroscience

Background:

  • Cisplatin is a common chemotherapy drug with known ototoxic side effects.
  • Ototoxicity affects multiple cochlear structures, including the stria vascularis, organ of Corti, and spiral ganglion.
  • The relationship between cisplatin-induced damage to the organ of Corti and spiral ganglion remains unclear.

Purpose of the Study:

  • To investigate the temporal relationship between cisplatin-induced ototoxicity in the organ of Corti and the spiral ganglion.
  • To determine if damage to these two cochlear structures occurs dependently or in parallel.

Main Methods:

  • Guinea pigs were administered daily intraperitoneal injections of cisplatin (2 mg/kg/day) for 4, 6, or 8 days.
  • Electrophysiological recordings were used to assess ototoxic effects as they developed.
  • Results were compared with previously published histological data.

Main Results:

  • The study's time-course analysis did not reveal evidence of one ototoxic process initiating another.
  • Electrophysiological findings support the hypothesis of parallel development of damage.
  • No indication of mutual dependence between organ of Corti and spiral ganglion damage was observed.

Conclusions:

  • Cisplatin-induced ototoxicity in the organ of Corti and the spiral ganglion occur in parallel.
  • These parallel processes are independent of each other.
  • The findings support previous research suggesting independent pathways for cisplatin-induced cochlear damage.

Related Concept Videos